New Onset Diabetes After Transplantation
Conditions
Brief summary
his study aims to utilize Continuous Glucose Monitoring (CGM) to observe glucose fluctuations in kidney transplant recipients and predict New-Onset Diabetes After Transplantation (NODAT) based on these patterns. Additionally, it seeks to investigate glucose variability resulting from medications and surgeries such as immunosuppressants and steroid regimens post-kidney transplantation. This prospective observational study anticipates identifying factors influencing blood glucose levels and contributing to future research on blood glucose management using CGM monitoring in kidney transplant patients.
Interventions
DIAGNOSTIC_TESTcontinuous glucose monitoring
FreeStyle Libre Flash Glucose Monitoring System
Sponsors
Seoul National University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* The study will target 100 kidney transplant patients who have provided consent, among those who underwent the procedure at Seoul National University Hospital after March 2021.
Exclusion criteria
* multi-organ transplant * history of previous kidney transplant * less than 18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of NODAT | 6 months after kidney transplantation | rate of new onset diabetes after transplantation |
Countries
South Korea
Contacts
Primary ContactJiyoung Sin, MD
Outcome results
None listed